Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese HSK 1 – For Medical Students & Physicians A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languages — free forever. Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese. By Bernd Sebastian Kamps and Andrea Melis

Pulmonary Hypertension

Free Subscription Articles published in J Cardiovasc Pharmacol Retrieve available abstracts of 17 articles: HTML format

Single Articles

April 2026
1. WANG YQ, Deng QY, Zhang ZZ, Wang GL, et al
   Short-Term Effect of Levosimendan in Acute Right Heart Failure Caused by Pulmonary Hypertension: A Pilot Study.
   J Cardiovasc Pharmacol. 2026 Apr 8. doi: 10.1097/FJC.0000000000001824.
   PubMed     Abstract available
   
   
   November 2025
2. ZHANG H, Ren J, He Y, Zhao K, et al
   GPX4: A Key Regulator of Mitochondrial Function and Glycolysis in Pulmonary Artery Smooth Muscle Cells.
   J Cardiovasc Pharmacol. 2025;86:489-497.
   PubMed     Abstract available
   
   
   July 2025
3. ZHU M, Xu F, Zhu L, Chen Q, et al
   FAP Promotes Pulmonary Artery Hypertension via Activation of the PTEN/PI3K/Akt Pathway.
   J Cardiovasc Pharmacol. 2025 Jul 17. doi: 10.1097/FJC.0000000000001735.
   PubMed     Abstract available
   
   
   February 2025
4. WANG S, Zhuo D, Lin J, Zhang C, et al
   Key Genes and Biological Pathways in Pulmonary Arterial Hypertension Related to Endoplasmic Reticulum Stress Identified by Bioinformatics.
   J Cardiovasc Pharmacol. 2025;85:108-119.
   PubMed     Abstract available
   
   
   January 2025
5. CHEN X, Xu L, Xue B
   Efficacy and safety of Treating Pulmonary Arterial Hypertension With Imatinib:A meta-analysis of randomized controlled trials.
   J Cardiovasc Pharmacol. 2025 Jan 2. doi: 10.1097/FJC.0000000000001665.
   PubMed     Abstract available
   
   
   July 2024
6. DENG J, Yang G, Zhong N, Liang L, et al
   Upregulation of Angiomotin-like 2 ameliorates experimental pulmonary arterial hypertension by inactivating YAP1 signaling.
   J Cardiovasc Pharmacol. 2024 Jul 2. doi: 10.1097/FJC.0000000000001606.
   PubMed     Abstract available
   
   
   May 2024
7. LUZ DE CASTRO A, Ortiz VD, Hickmann AR, Lacerda DS, et al
   EFFECTS OF PTEROSTILBENE ON HEART AND LUNG OXIDATIVE STRESS PARAMETERS IN TWO EXPERIMENTAL MODELS OF CARDIOVASCULAR DISEASE: MYOCARDIAL INFARCTION AND PULMONARY ARTERIAL HYPERTENSION.
   J Cardiovasc Pharmacol. 2024 May 4. doi: 10.1097/FJC.0000000000001572.
   PubMed     Abstract available
   
   
   March 2024
8. CONZATTI A, Colombo R, Siqueira R, Campos-Carraro C, et al
   Sulforaphane improves redox homeostasis and right ventricular contractility in a model of pulmonary hypertension.
   J Cardiovasc Pharmacol. 2024 Mar 14. doi: 10.1097/FJC.0000000000001557.
   PubMed     Abstract available
   
   
   January 2024
9. KUMARI K, Vishwakarma VK, Kumar K, Mridha AR, et al
   Effect of benidipine alone and in combination with bosentan and sildenafil in amelioration of pulmonary arterial hypertension in experimental model in rats.
   J Cardiovasc Pharmacol. 2024 Jan 17. doi: 10.1097/FJC.0000000000001541.
   PubMed     Abstract available
   
   
   
10. LI J, He X, Liu F, Zheng X, et al
    Tumor Necrosis Factor-alpha-Induced Protein-8-like 2 Transfected Adipose-Derived Stem Cells Regulated the Dysfunction of Monocrotaline Pyrrole-Induced Pulmonary Arterial Smooth Muscle Cells and Pulmonary Arterial Endothelial Cells.
    J Cardiovasc Pharmacol. 2024;83:73-85.
    PubMed     Abstract available
    
    
    December 2023
11. ATEFIPOUR N, Dianat M, Badavi M, Radan M, et al
    The Role of Rosmarinic Acid in the Protection against Inflammatory Factors in Rats Model with Monocrotaline-Induced Pulmonary Hypertension: Investigating the Signaling Pathway of NFkappaB, OPG, Runx2, and P-selectin in Heart.
    J Cardiovasc Pharmacol. 2023 Dec 26. doi: 10.1097/FJC.0000000000001534.
    PubMed     Abstract available
    
    
    September 2023
12. BROCKMOLLER J, Ivanoski S, Hundack L, Blohm JH, et al
    Clinical and hemodynamic improvement in pulmonary hypertension after switching to sacubitril/valsartan in heart failure patients with preserved ejection fraction.
    J Cardiovasc Pharmacol. 2023 Sep 1. doi: 10.1097/FJC.0000000000001477.
    PubMed     Abstract available
    
    
    April 2023
13. LI SS, Liang S, Li L, Yang H, et al
    circNFXL1 Modulates the Kv2.1 Channel Function in Hypoxic Human Pulmonary Artery Smooth Muscle Cells via Sponging miR-29b-2-5p as a Competitive Endogenous RNA.
    J Cardiovasc Pharmacol. 2023;81:292-299.
    PubMed     Abstract available
    
    
    October 2022
14. KANG L, Liu X, Li Z, Li X, et al
    Sildenafil improves pulmonary vascular remodeling in a rat model of persistent pulmonary hypertension of the newborn.
    J Cardiovasc Pharmacol. 2022 Oct 1. pii: 00005344-990000000-00118.
    PubMed     Abstract available
    
    
    July 2022
15. IMAM SS, El-Farrash RA, Taha AS, Saleh GA, et al
    Milrinone Versus Sildenafil in Treatment of Neonatal Persistent Pulmonary Hypertension: A Randomized Control Trial.
    J Cardiovasc Pharmacol. 2022 Jul 12. pii: 00005344-990000000-00081.
    PubMed     Abstract available
    
    
    May 2022
16. CAI H, Fan S, Cai L, Zhu L, et al
    Dihydroartemisinin attenuates hypoxia-induced pulmonary hypertension through the ELAVL2/miR-503/PI3K/AKT axis.
    J Cardiovasc Pharmacol. 2022 May 5. pii: 00005344-990000000-00028.
    PubMed     Abstract available
    
    
    
17. 
    ZIP12 Contributes to Hypoxic Pulmonary Hypertension by Driving Phenotypic Switching of Pulmonary Artery Smooth Muscle Cells: Erratum.
    J Cardiovasc Pharmacol. 2022;79:758.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum